Loading…
Expanding spectrum of “spitzoid” lesions: a small series of 4 cases with MAP2K1 mutations
The molecular background of a significant proportion of spitzoid neoplasms is still unknown. Recently, activating mutations in MAP2K1 have been described in a few spitzoid lesions, but not in benign Spitz nevi. We report four cases of melanocytic tumors with spitzoid features in which a MAP2K1 mutat...
Saved in:
Published in: | Virchows Archiv : an international journal of pathology 2021-07, Vol.479 (1), p.195-202 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c3663-8a0f4d1f7a7fe5b08a40dee48e6ab3a500a624437702d02fd87a51e299d845323 |
---|---|
cites | cdi_FETCH-LOGICAL-c3663-8a0f4d1f7a7fe5b08a40dee48e6ab3a500a624437702d02fd87a51e299d845323 |
container_end_page | 202 |
container_issue | 1 |
container_start_page | 195 |
container_title | Virchows Archiv : an international journal of pathology |
container_volume | 479 |
creator | Kerckhoffs, K. G. P. Aallali, T. Ambarus, C. A. Sigurdsson, V. Jansen, A. M. L. Blokx, W. A. M. |
description | The molecular background of a significant proportion of spitzoid neoplasms is still unknown. Recently, activating mutations in
MAP2K1
have been described in a few spitzoid lesions, but not in benign Spitz nevi. We report four cases of melanocytic tumors with spitzoid features in which a
MAP2K1
mutation was detected. The lesions did not show a single distinct phenotype and ranged from benign to malignant. Two cases resembled desmoplastic Spitz nevi. Based on the combination of morphological, immunohistochemical, and molecular findings, one case was classified as benign, one as probably benign, possibly intermediate low-grade (MELTUMP—melanocytic tumor of unknown malignant potential), one case was classified as intermediate (MELTUMP), and one case was considered a superficial spreading melanoma with spitzoid features. Based on this, we conclude that
MAP2K1
mutations can indicate a spitzoid genetic signature and can be found in both benign and malignant spitzoid neoplasms. |
doi_str_mv | 10.1007/s00428-020-02940-3 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8298358</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2450008491</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3663-8a0f4d1f7a7fe5b08a40dee48e6ab3a500a624437702d02fd87a51e299d845323</originalsourceid><addsrcrecordid>eNp9kc1O3TAQhS1UBLfQF-jKUjfdpIx_kjhdVEKIFlQqWMCysnyTycUoiVNP0r8VD1JejiepLxe1ahcsLFua7xyd8WHspYA3AqA8IAAtTQYS0qk0ZGqLLYRWMpMKymdsAZXOs0KJcpc9J7oBkMKIYoftKgUaRCEW7PPx99ENjR9WnEaspzj3PLT8_vYXjX76GXxzf3vHOyQfBnrLHafedR0njB5pTWpeO0rPb3665p8OL-RHwft5ctNasM-2W9cRvni899jV--PLo5Ps7PzD6dHhWVarolCZcdDqRrSlK1vMl2CchgZRGyzcUrkcwBVSa1WWIBuQbWNKlwuUVdUYnSup9ti7je84L3tsahym6Do7Rt-7-MMG5-2_k8Ff21X4ao2sjMpNMnj9aBDDlxlpsr2nGrvODRhmslKnEGB0JRL66j_0JsxxSOtZmedapO9WVaLkhqpjIIrY_gkjwK7bs5v2bGrPPrRnVRKpjYgSPKww_rV-QvUb3mycgQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2554131739</pqid></control><display><type>article</type><title>Expanding spectrum of “spitzoid” lesions: a small series of 4 cases with MAP2K1 mutations</title><source>Springer Nature:Jisc Collections:Springer Nature Read and Publish 2023-2025: Springer Reading List</source><creator>Kerckhoffs, K. G. P. ; Aallali, T. ; Ambarus, C. A. ; Sigurdsson, V. ; Jansen, A. M. L. ; Blokx, W. A. M.</creator><creatorcontrib>Kerckhoffs, K. G. P. ; Aallali, T. ; Ambarus, C. A. ; Sigurdsson, V. ; Jansen, A. M. L. ; Blokx, W. A. M.</creatorcontrib><description>The molecular background of a significant proportion of spitzoid neoplasms is still unknown. Recently, activating mutations in
MAP2K1
have been described in a few spitzoid lesions, but not in benign Spitz nevi. We report four cases of melanocytic tumors with spitzoid features in which a
MAP2K1
mutation was detected. The lesions did not show a single distinct phenotype and ranged from benign to malignant. Two cases resembled desmoplastic Spitz nevi. Based on the combination of morphological, immunohistochemical, and molecular findings, one case was classified as benign, one as probably benign, possibly intermediate low-grade (MELTUMP—melanocytic tumor of unknown malignant potential), one case was classified as intermediate (MELTUMP), and one case was considered a superficial spreading melanoma with spitzoid features. Based on this, we conclude that
MAP2K1
mutations can indicate a spitzoid genetic signature and can be found in both benign and malignant spitzoid neoplasms.</description><identifier>ISSN: 0945-6317</identifier><identifier>EISSN: 1432-2307</identifier><identifier>DOI: 10.1007/s00428-020-02940-3</identifier><identifier>PMID: 33040161</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Benign ; Brief Report ; Lesions ; Medicine ; Medicine & Public Health ; Melanoma ; Mutation ; Neoplasms ; Pathology ; Phenotypes ; Tumors</subject><ispartof>Virchows Archiv : an international journal of pathology, 2021-07, Vol.479 (1), p.195-202</ispartof><rights>The Author(s) 2020</rights><rights>The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3663-8a0f4d1f7a7fe5b08a40dee48e6ab3a500a624437702d02fd87a51e299d845323</citedby><cites>FETCH-LOGICAL-c3663-8a0f4d1f7a7fe5b08a40dee48e6ab3a500a624437702d02fd87a51e299d845323</cites><orcidid>0000-0002-3108-6412</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids></links><search><creatorcontrib>Kerckhoffs, K. G. P.</creatorcontrib><creatorcontrib>Aallali, T.</creatorcontrib><creatorcontrib>Ambarus, C. A.</creatorcontrib><creatorcontrib>Sigurdsson, V.</creatorcontrib><creatorcontrib>Jansen, A. M. L.</creatorcontrib><creatorcontrib>Blokx, W. A. M.</creatorcontrib><title>Expanding spectrum of “spitzoid” lesions: a small series of 4 cases with MAP2K1 mutations</title><title>Virchows Archiv : an international journal of pathology</title><addtitle>Virchows Arch</addtitle><description>The molecular background of a significant proportion of spitzoid neoplasms is still unknown. Recently, activating mutations in
MAP2K1
have been described in a few spitzoid lesions, but not in benign Spitz nevi. We report four cases of melanocytic tumors with spitzoid features in which a
MAP2K1
mutation was detected. The lesions did not show a single distinct phenotype and ranged from benign to malignant. Two cases resembled desmoplastic Spitz nevi. Based on the combination of morphological, immunohistochemical, and molecular findings, one case was classified as benign, one as probably benign, possibly intermediate low-grade (MELTUMP—melanocytic tumor of unknown malignant potential), one case was classified as intermediate (MELTUMP), and one case was considered a superficial spreading melanoma with spitzoid features. Based on this, we conclude that
MAP2K1
mutations can indicate a spitzoid genetic signature and can be found in both benign and malignant spitzoid neoplasms.</description><subject>Benign</subject><subject>Brief Report</subject><subject>Lesions</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Melanoma</subject><subject>Mutation</subject><subject>Neoplasms</subject><subject>Pathology</subject><subject>Phenotypes</subject><subject>Tumors</subject><issn>0945-6317</issn><issn>1432-2307</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kc1O3TAQhS1UBLfQF-jKUjfdpIx_kjhdVEKIFlQqWMCysnyTycUoiVNP0r8VD1JejiepLxe1ahcsLFua7xyd8WHspYA3AqA8IAAtTQYS0qk0ZGqLLYRWMpMKymdsAZXOs0KJcpc9J7oBkMKIYoftKgUaRCEW7PPx99ENjR9WnEaspzj3PLT8_vYXjX76GXxzf3vHOyQfBnrLHafedR0njB5pTWpeO0rPb3665p8OL-RHwft5ctNasM-2W9cRvni899jV--PLo5Ps7PzD6dHhWVarolCZcdDqRrSlK1vMl2CchgZRGyzcUrkcwBVSa1WWIBuQbWNKlwuUVdUYnSup9ti7je84L3tsahym6Do7Rt-7-MMG5-2_k8Ff21X4ao2sjMpNMnj9aBDDlxlpsr2nGrvODRhmslKnEGB0JRL66j_0JsxxSOtZmedapO9WVaLkhqpjIIrY_gkjwK7bs5v2bGrPPrRnVRKpjYgSPKww_rV-QvUb3mycgQ</recordid><startdate>20210701</startdate><enddate>20210701</enddate><creator>Kerckhoffs, K. G. P.</creator><creator>Aallali, T.</creator><creator>Ambarus, C. A.</creator><creator>Sigurdsson, V.</creator><creator>Jansen, A. M. L.</creator><creator>Blokx, W. A. M.</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7T7</scope><scope>7TM</scope><scope>7TO</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-3108-6412</orcidid></search><sort><creationdate>20210701</creationdate><title>Expanding spectrum of “spitzoid” lesions: a small series of 4 cases with MAP2K1 mutations</title><author>Kerckhoffs, K. G. P. ; Aallali, T. ; Ambarus, C. A. ; Sigurdsson, V. ; Jansen, A. M. L. ; Blokx, W. A. M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3663-8a0f4d1f7a7fe5b08a40dee48e6ab3a500a624437702d02fd87a51e299d845323</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Benign</topic><topic>Brief Report</topic><topic>Lesions</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Melanoma</topic><topic>Mutation</topic><topic>Neoplasms</topic><topic>Pathology</topic><topic>Phenotypes</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kerckhoffs, K. G. P.</creatorcontrib><creatorcontrib>Aallali, T.</creatorcontrib><creatorcontrib>Ambarus, C. A.</creatorcontrib><creatorcontrib>Sigurdsson, V.</creatorcontrib><creatorcontrib>Jansen, A. M. L.</creatorcontrib><creatorcontrib>Blokx, W. A. M.</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Virchows Archiv : an international journal of pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kerckhoffs, K. G. P.</au><au>Aallali, T.</au><au>Ambarus, C. A.</au><au>Sigurdsson, V.</au><au>Jansen, A. M. L.</au><au>Blokx, W. A. M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Expanding spectrum of “spitzoid” lesions: a small series of 4 cases with MAP2K1 mutations</atitle><jtitle>Virchows Archiv : an international journal of pathology</jtitle><stitle>Virchows Arch</stitle><date>2021-07-01</date><risdate>2021</risdate><volume>479</volume><issue>1</issue><spage>195</spage><epage>202</epage><pages>195-202</pages><issn>0945-6317</issn><eissn>1432-2307</eissn><abstract>The molecular background of a significant proportion of spitzoid neoplasms is still unknown. Recently, activating mutations in
MAP2K1
have been described in a few spitzoid lesions, but not in benign Spitz nevi. We report four cases of melanocytic tumors with spitzoid features in which a
MAP2K1
mutation was detected. The lesions did not show a single distinct phenotype and ranged from benign to malignant. Two cases resembled desmoplastic Spitz nevi. Based on the combination of morphological, immunohistochemical, and molecular findings, one case was classified as benign, one as probably benign, possibly intermediate low-grade (MELTUMP—melanocytic tumor of unknown malignant potential), one case was classified as intermediate (MELTUMP), and one case was considered a superficial spreading melanoma with spitzoid features. Based on this, we conclude that
MAP2K1
mutations can indicate a spitzoid genetic signature and can be found in both benign and malignant spitzoid neoplasms.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>33040161</pmid><doi>10.1007/s00428-020-02940-3</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-3108-6412</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0945-6317 |
ispartof | Virchows Archiv : an international journal of pathology, 2021-07, Vol.479 (1), p.195-202 |
issn | 0945-6317 1432-2307 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8298358 |
source | Springer Nature:Jisc Collections:Springer Nature Read and Publish 2023-2025: Springer Reading List |
subjects | Benign Brief Report Lesions Medicine Medicine & Public Health Melanoma Mutation Neoplasms Pathology Phenotypes Tumors |
title | Expanding spectrum of “spitzoid” lesions: a small series of 4 cases with MAP2K1 mutations |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T12%3A27%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Expanding%20spectrum%20of%20%E2%80%9Cspitzoid%E2%80%9D%20lesions:%20a%20small%20series%20of%204%20cases%20with%20MAP2K1%20mutations&rft.jtitle=Virchows%20Archiv%20:%20an%20international%20journal%20of%20pathology&rft.au=Kerckhoffs,%20K.%20G.%20P.&rft.date=2021-07-01&rft.volume=479&rft.issue=1&rft.spage=195&rft.epage=202&rft.pages=195-202&rft.issn=0945-6317&rft.eissn=1432-2307&rft_id=info:doi/10.1007/s00428-020-02940-3&rft_dat=%3Cproquest_pubme%3E2450008491%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3663-8a0f4d1f7a7fe5b08a40dee48e6ab3a500a624437702d02fd87a51e299d845323%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2554131739&rft_id=info:pmid/33040161&rfr_iscdi=true |